Joanna Nowacka joins Dynamic42 as Lead for Stem Cell Model Development
We are delighted to announce that Joanna Nowacka has recently joined Dynamic42 as a scientist. Joanna is from Warsaw in Poland and brings along a remarkable background in biotechnology, having graduated summa cum laude from the University of Warsaw. Her scientist journey includes two notable internships in the USA at the Dana-Farber Cancer Institute and the University of Virginia, further enhancing her expertise in cancer research and biotechnology. We are very happy to have Joanna support our research team.
Embracing the future of Drug Testing Models
Currently, Joanna finished her industrial Ph.D. project in Miltenyi Biotec with the affiliation at the University of Tübingen. This project, as part of the prestigious Marie-Skłodowska-Curie Actions program, focused on developing innovative heart-on-a-chip for applications in cellular therapies. This multidisciplinary experience perfectly aligns with Dynamic42’s cutting-edge research and development initiatives. In the context of personalized medicine, Joanna will develop stem cell cultures into “pluripotent” stem cells. From this, each type of cell can then be distinguished.
Joanne will be working on a vascularized liver-on-chip model for personalized compound testing (Vascu Chip). This Project is financed by the directive of the Free State of Thuringia on the Promotion of Research, Technology and Innovation (FTI) of 19.02.2024, entered into force on 20.02.2024 (ThürStAnz.-Nr. 11/2024 from 11.03.2024, S. 428-429).
I believe organ-on-chip technology represents the future of drug testing models. I am eager to join Dynamic42 to contribute my stem cell expertise to their already remarkable platforms.
Beyond the Lab
In her free time, Joanna enjoys immersing herself in various activities. She likes reading, finds creativity in knitting, and experiments with new cooking recipes.
Read more News:
Cancer, rheumatism, asthma: organ-on-chip models highly relevant for preclinical testing of therapeutic antibodies
Improving people’s lives with innovative technologies. This was the goal that Jena-based Dynamic42 had in mind 18 months ago when they launched a project – funded as part of the Sanofi iDEA-iTECH Award Program.
ATHANA alliance for antifungal therapy approaches – First strategy workshop
The RUBIN alliance “ATHANA” met for their first strategy workshop one year after the project kicked off in summer last year.
Amélie Marie Paillereau joins Dynamic42 as Master Student funded by the Thuringia and European Social Fund Plus
We are excited to welcome Amélie Marie Paillereau to the Dynamic42 science team. Amélie started in April with us for a 12-month-long Master thesis, focusing on perfused breast and pancreatic cancer-on-chip models to study the impact of the tumor microenvironment on immune cell invasion.